Skip to main content

Advertisement

Log in

A Case of Vogt-Koyanagi-Harada Disease Associated with Malignant Lymphoma

  • BRIEF COMMUNICATION
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Vogt-Koyanagi-Harada disease (VKH), an inflammatory ocular disorder characterized by bilateral granulomatous panuveitis and a variety of extraocular manifestations, has been reported to be associated with various immune disorders but has not been linked to malignant lymphoma (ML).

Case

We present here a case of VKH associated with a recurrence of ML.

Observations

A 69-year-old man who initially had ML presented with a history of sudden bilateral visual acuity loss. Funduscopy showed papilloedema and serous retinal detachment in both eyes, and a diagnosis of VKH was reached soon thereafter. Chest X-ray and an abdominal computed tomography scan indicated the metastatic focus of the ML. A recurrence was suspected because the ML-associated soluble interleukin-2 receptor (sIL-2R) in the serum was highly elevated. Treatment successfully resolved both the ML and the VKH. The inflammatory activities of VKH and ML were found to correlate with the serum levels of sIL-2R.

Conclusions

This case suggests an association between sIL-2R levels and disease activity in VKH and ML, and provides additional evidence that VKH can be induced by immune disorders caused by high sIL-2R levels in ML. Jpn J Ophthalmol 2005;49:253–256 © Japanese Ophthalmological Society 2005

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noriyasu Hashida.

About this article

Cite this article

Hashida, N., Kanayama, S., Kawasaki, A. et al. A Case of Vogt-Koyanagi-Harada Disease Associated with Malignant Lymphoma. Jpn J Ophthalmol 49, 253–256 (2005). https://doi.org/10.1007/s10384-004-0177-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-004-0177-5

Key words

Navigation